Cargando…

Organelle-Partitioned Sugar–Rhodamine Diad for In Vivo Tumor Imaging

[Image: see text] Current tumor imaging agents are often limited by their liability to dissipate from tumor tissues. As cell sugar sorting enables exogenous sugars to be delivered into predetermined subcellular locations, we synthesized sialic acid (Sia) derivatives with rhodamine-X conjugated at C-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Enkang, Yu, Chaozhang, Tang, Hui, Li, Yuntong, Zuo, Dongliang, Yang, Rongshui, Ma, Chao, Miao, Jiayin, Liu, Pingguo, Su, Xinhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408233/
https://www.ncbi.nlm.nih.gov/pubmed/32775903
http://dx.doi.org/10.1021/acsomega.0c02323
Descripción
Sumario:[Image: see text] Current tumor imaging agents are often limited by their liability to dissipate from tumor tissues. As cell sugar sorting enables exogenous sugars to be delivered into predetermined subcellular locations, we synthesized sialic acid (Sia) derivatives with rhodamine-X conjugated at C-9 ((ROX)Sia), which hitchhikes cell sialic acid sorting to target tumor cell lysosomes, exhibiting pH-independent long-term probe retention in lysosomes. (ROX)Sia gives selective, bright, and endured fluorescence signals in subcutaneous tumors and orthotopic tumors in mice models. These results indicate the potential of (ROX)Sia as a lysosome-targeted optical agent for fluorescence-guided tumor resection.